BRUNELLI, Matteo
 Distribuzione geografica
Continente #
EU - Europa 23.182
NA - Nord America 19.509
AS - Asia 13.844
SA - Sud America 2.122
AF - Africa 352
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 15
Totale 59.060
Nazione #
US - Stati Uniti d'America 18.875
RU - Federazione Russa 9.399
SG - Singapore 5.457
CN - Cina 4.635
GB - Regno Unito 4.502
IT - Italia 2.434
BR - Brasile 1.749
SE - Svezia 1.425
HK - Hong Kong 1.412
DE - Germania 1.368
IE - Irlanda 1.087
FR - Francia 1.039
VN - Vietnam 936
FI - Finlandia 829
CA - Canada 425
KR - Corea 358
UA - Ucraina 225
NL - Olanda 221
JP - Giappone 189
IN - India 160
TR - Turchia 141
AR - Argentina 140
MX - Messico 137
PL - Polonia 122
ES - Italia 119
BE - Belgio 112
BD - Bangladesh 98
ZA - Sudafrica 89
ID - Indonesia 84
AT - Austria 70
EC - Ecuador 69
LT - Lituania 66
TG - Togo 62
IQ - Iraq 57
BJ - Benin 52
CO - Colombia 45
MA - Marocco 38
PK - Pakistan 34
PY - Paraguay 31
VE - Venezuela 30
AU - Australia 29
CZ - Repubblica Ceca 29
AE - Emirati Arabi Uniti 28
UZ - Uzbekistan 27
IR - Iran 26
CL - Cile 25
EG - Egitto 21
JO - Giordania 20
KE - Kenya 20
AZ - Azerbaigian 18
IL - Israele 15
SA - Arabia Saudita 15
CH - Svizzera 14
LV - Lettonia 14
PE - Perù 14
TN - Tunisia 14
KZ - Kazakistan 13
BG - Bulgaria 11
DO - Repubblica Dominicana 11
PH - Filippine 11
CI - Costa d'Avorio 10
HN - Honduras 10
HU - Ungheria 10
JM - Giamaica 10
MY - Malesia 10
NP - Nepal 10
PA - Panama 10
PS - Palestinian Territory 10
UY - Uruguay 10
AM - Armenia 9
DZ - Algeria 9
KG - Kirghizistan 9
PT - Portogallo 9
DK - Danimarca 8
EU - Europa 8
GR - Grecia 8
LK - Sri Lanka 8
TW - Taiwan 8
AL - Albania 7
CR - Costa Rica 7
BO - Bolivia 6
IM - Isola di Man 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
RO - Romania 6
SN - Senegal 6
BY - Bielorussia 5
EE - Estonia 5
ET - Etiopia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SV - El Salvador 5
AO - Angola 4
GT - Guatemala 4
HR - Croazia 4
KH - Cambogia 4
MD - Moldavia 4
MK - Macedonia 4
NO - Norvegia 4
OM - Oman 4
Totale 58.974
Città #
Southend 3.738
Moscow 3.160
Singapore 2.691
Chandler 2.463
Dallas 2.125
Ashburn 1.721
Hong Kong 1.399
Jacksonville 1.331
Dublin 1.074
Woodbridge 1.067
Beijing 960
Ann Arbor 959
New York 600
Houston 497
The Dalles 490
Munich 487
Los Angeles 481
Verona 391
Lawrence 366
Princeton 366
Wilmington 343
Jinan 331
Ho Chi Minh City 294
Helsinki 283
Nanjing 248
Shenyang 229
Montréal 195
São Paulo 192
Mcallen 179
Columbus 176
Milan 175
Tokyo 175
Hebei 174
Hanoi 173
Buffalo 172
Tianjin 169
Redondo Beach 168
Rome 165
Santa Clara 154
Turku 146
Sindelfingen 133
Dearborn 131
Zhengzhou 126
London 117
Redmond 116
Seattle 110
Seoul 109
Brussels 107
Ningbo 106
Changsha 104
Denver 100
Warsaw 98
Guangzhou 96
Boardman 94
Taizhou 94
Bologna 92
Montreal 92
Brooklyn 90
Haikou 88
Orem 87
Stockholm 86
Nanchang 79
Frankfurt am Main 75
Redwood City 74
Hangzhou 70
Taiyuan 70
Mexico City 68
Atlanta 67
Jiaxing 66
Lancaster 66
Chennai 65
San Francisco 65
Chicago 64
Lomé 61
Poplar 61
Amsterdam 59
Johannesburg 59
Dong Ket 57
Toronto 56
Phoenix 54
Rio de Janeiro 53
Cotonou 52
Norwalk 52
Boston 48
Volga 47
Nuremberg 46
Belo Horizonte 45
Haiphong 43
Jakarta 43
Vienna 39
Fairfield 38
Da Nang 37
Lanzhou 37
Manchester 37
Falkenstein 36
Washington 36
Kent 35
Shanghai 35
Ankara 34
Detroit 33
Totale 34.745
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 884
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 636
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 357
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 288
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 261
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 241
Schwannoma del rene 237
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 230
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 229
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 225
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 222
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 219
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 217
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 217
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 213
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 213
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 211
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 210
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 207
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 205
Una complessa valutazione della vitalità delle fratture in ambito forense 204
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 203
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 202
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 199
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 199
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 197
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 195
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 195
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 195
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 193
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 193
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 193
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 192
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 191
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 191
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 190
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 190
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 190
CD10 is expressed in a subset of chromophobe renal cell carcinomas 189
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 189
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 188
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 188
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 185
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 185
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 184
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 184
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 183
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 183
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 183
Chondroid syringoma with extensive ossification 183
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 182
Adenocarcinoma of the paraurethral glands: a case report 181
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 181
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 180
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 179
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 179
Liver Metastases From Renal Oncocytoma With Vascular Extension 178
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 177
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 176
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 176
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 175
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 175
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 174
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 174
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 174
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 174
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 173
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 173
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 173
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 173
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 173
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 172
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 172
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 172
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 171
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 171
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 171
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 171
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 170
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 170
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 170
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 169
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 169
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 168
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 168
Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study 167
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 167
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 167
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 167
[Diagnostic and prognostic markers in renal tumors] 166
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 166
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 166
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory Analysis 166
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 166
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 165
Rapid screening for malignancy in organ donors. 15 years experience with the Verona "Alert" protocol and review of the literature 163
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 163
Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses 162
Expression of GATA-3 among renal cell and urothelial neoplasms 162
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 162
Totale 20.017
Categoria #
all - tutte 204.816
article - articoli 186.326
book - libri 0
conference - conferenze 18.130
curatela - curatele 0
other - altro 360
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 409.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.466 0 0 0 0 0 354 105 150 124 62 414 257
2021/20223.068 332 737 51 338 150 132 50 208 93 85 228 664
2022/20237.019 458 769 614 1.185 605 1.731 72 478 763 72 162 110
2023/20244.069 172 298 330 445 479 668 198 246 67 279 636 251
2024/202510.103 507 543 549 1.652 427 350 571 447 1.427 685 980 1.965
2025/202621.842 2.058 1.611 2.348 5.573 8.280 1.972 0 0 0 0 0 0
Totale 59.971